Myriad Genetics MYGN Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's other accrued liabilities?
- Myriad Genetics (MYGN) reported other accrued liabilities of $20.1M in Q1 2026.
- How has Myriad Genetics's other accrued liabilities changed year-over-year?
- Myriad Genetics's other accrued liabilities decreased by 27.4% year-over-year, from $27.7M to $20.1M.
- What is the long-term trend for Myriad Genetics's other accrued liabilities?
- Over 5 years (2020 to 2025), Myriad Genetics's other accrued liabilities has grown at a 10.4% compound annual growth rate (CAGR), from $9.4M to $15.4M.